Search for bosonic super-WIMP interactions with the XENON100 experiment

dc.citation.articleNumber122002
dc.citation.issueNumber12
dc.citation.journalTitlePhysical Review D
dc.citation.volumeNumber96
dc.contributor.authorXENON Collaboration
dc.date.accessioned2019-01-03T16:59:04Z
dc.date.available2019-01-03T16:59:04Z
dc.date.issued2017
dc.description.abstractWe present results of searches for vector and pseudoscalar bosonic super-weakly interacting massive particles (WIMPs), which are dark matter candidates with masses at the keV-scale, with the XENON100 experiment. XENON100 is a dual-phase xenon time projection chamber operated at the Laboratori Nazionali del Gran Sasso. A profile likelihood analysis of data with an exposure of 224.6 live days ×34 kg showed no evidence for a signal above the expected background. We thus obtain new and stringent upper limits in the (8–125) keV/c2 mass range, excluding couplings to electrons with coupling constants of gae>3×10−13 for pseudo-scalar and α′/α>2×10−28 for vector super-WIMPs, respectively. These limits are derived under the assumption that super-WIMPs constitute all of the dark matter in our galaxy.
dc.identifier.citationXENON Collaboration. "Search for bosonic super-WIMP interactions with the XENON100 experiment." <i>Physical Review D,</i> 96, no. 12 (2017) American Physical Society: https://doi.org/10.1103/PhysRevD.96.122002.
dc.identifier.doihttps://doi.org/10.1103/PhysRevD.96.122002
dc.identifier.urihttps://hdl.handle.net/1911/104951
dc.language.isoeng
dc.publisherAmerican Physical Society
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
dc.titleSearch for bosonic super-WIMP interactions with the XENON100 experiment
dc.typeJournal article
dc.type.dcmiText
dc.type.publicationpublisher version
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PhysRevD.96.122002.pdf
Size:
455 KB
Format:
Adobe Portable Document Format
Description: